We outline the general conditions under which chemicals of high hydrophobicity or, more generally, high partition ratios (HPRs) in water or air, may experience unexpectedly long kinetic delays in approaching equilibrium conditions with organic media. Such a "hydrophobic delay" in the case of K or an "aerophobic" delay in the case of K may be misinterpreted as being caused by a change in partitioning behavior or mechanism, resulting in development of nonlinear regression models describing intermedia partitioning. In fact, the partitioning is fundamentally linear but is distorted by a kinetic delay in partitioning. To illustrate this concept, we first compile the fundamental equations describing the diffusive equilibration processes, including a complementary transport mechanism termed a parallel particle pathway (PPP). Such a mechanism may occur simultaneously, shortening the HPR delay and complicating interpretation. Second, we describe five examples in which the HPR delay explains the observed and occasionally difficult-to-interpret environmental behavior of chemicals, namely studies of air-aerosol partitioning, chemical accumulation in indoor dust and surfaces, air-vegetation partitioning, internal transport in organisms, and fish bioaccumulation and toxicity. We believe that the general HPR delay and PPP issues deserve exposure as a commonly occurring and often underappreciated process.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.est.8b04514 | DOI Listing |
J Clin Med
April 2024
Center for Intensive Internal Medicine, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.
Comatose survivors of out-of-hospital cardiac arrest (OHCA) undergoing percutaneous coronary intervention (PCI) and target temperature management (TTM) are at increased risk of stent thrombosis (ST), partly due to delayed platelet inhibition even with more potent P2Y agents. We hypothesized that periprocedural cangrelor would induce immediate platelet inhibition, bridging the "P2Y inhibition gap". In our pilot study, we randomized 30 comatose OHCA patients undergoing PCI and TTM (32-34 °C) into cangrelor and control groups.
View Article and Find Full Text PDFAnn Phys Rehabil Med
April 2024
Agence Régionale de Santé Ile de France, 13 rue du Landy, Saint Denis 93200, France; AP-HP, GH Paris Saclay, Hôpital Raymond Poincaré, service de Médecine Physique et de Réadaptation 104, boulevard Raymond Poincaré, Garches 92380, France; Equipe INSERM DevPsy, CESP, UMR 1018, Université Paris-Saclay, UVSQ, France. Electronic address:
Front Netw Physiol
August 2023
Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Radiographics
May 2022
From the Division of Head and Neck Radiology, Diagnósticos da América SA/DASA, São Paulo, Brazil (P.H.P.R., R.M.R., S.A.S., M.O.S., M.B.C., M.R.T.G.); Division of Head and Neck Radiology, Instituto Nacional do Câncer (INCA), Rio de Janeiro, Brazil (M.D.); Departments of Diagnostic Imaging (S.A.S., M.B.C.) and Radiation Therapy (L.A.B.T.), Instituto do Câncer do Estado de São Paulo (ICESP) do HCFMUSP, São Paulo, Brazil; Department of Radiation Therapy, Hospital Santa Paula, São Paulo, Brazil (L.A.B.T.); Division of Head and Neck and Neuroradiology, Grupo São Camilo/ DASA, Maringá, Brazil (A.L.J.); Division of Head and Neck Radiology, Instituto de Radiologia, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (InRad/ HC-FMUSP), São Paulo, Brazil (M.O.S.); and Department of Radiology, UT Southwestern Medical Center, Dallas, Tex (M.C.P.).
Whether used as a single modality or as part of a combined approach, radiation therapy (RT) plays an essential role in the treatment of several head and neck malignancies. Despite the improvement in radiation delivery techniques, normal structures in the vicinity of the target area remain susceptible to a wide range of adverse effects. Given their high incidence, some of these effects are referred to as expected postradiation changes (eg, mucositis, sialadenitis, and edema), while others are considered true complications, meaning they should not be expected and can even represent life-threatening conditions (eg, radionecrosis, fistulas, and radiation-induced neoplasms).
View Article and Find Full Text PDFElife
March 2022
Department of Cardiology and Cardiovascular Research Institute of PLA, General Hospital of Northern Theater Command, Shenyang, China.
Background: Ticagrelor is a first-line drug for the treatment of acute ST elevation myocardial infarction (STEMI). However, approximately 20% STEMI patients taking ticagrelor exhibited a delayed response and the mechanism was still unclear.
Methods: To explore the mechanism of the poor response of ticagrelor in post-percutaneous coronary intervention (PCI) patients, we enrolled 65 high platelet reactivity (HPR) patients and 90 controls (normal platelet reactivity [NPR]).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!